Filing Details
- Accession Number:
- 0000014272-20-000281
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-23 17:40:27
- Reporting Period:
- 2020-11-19
- Accepted Time:
- 2020-11-23 17:40:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1677618 | Rupert Vessey | 430 E. 29Th Street 14Th Floor New York NY 10016 | Evp, Research & Early Dev. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Disposition | 2020-11-19 | 10,579 | $61.25 | 46,142 | No | 4 | S | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2020-11-19 | 14,515 | $54.94 | 60,657 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2020-11-19 | 12,233 | $54.29 | 72,890 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2020-11-19 | 8,489 | $44.70 | 81,379 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2020-11-19 | 8,489 | $47.81 | 89,868 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2020-11-19 | 8,487 | $38.41 | 98,355 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2020-11-19 | 47,012 | $61.31 | 51,343 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2020-11-19 | 14,515 | $0.00 | 14,515 | $54.94 |
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2020-11-19 | 12,233 | $0.00 | 12,233 | $54.29 |
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2020-11-19 | 8,489 | $0.00 | 8,489 | $44.70 |
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2020-11-19 | 8,489 | $0.00 | 8,489 | $47.81 |
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2020-11-19 | 8,487 | $0.00 | 8,487 | $38.41 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2026-10-31 | No | 4 | M | Direct | |
| 12,233 | 2027-10-30 | No | 4 | M | Direct | |
| 16,980 | 2028-05-08 | No | 4 | M | Direct | |
| 16,980 | 2028-07-30 | No | 4 | M | Direct | |
| 16,981 | 2028-10-29 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $0.10 Par Value | 613 | Indirect | 401(k) |
Footnotes
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $61.19 to $61.29, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- 47,012 of the shares sold were to cover the exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $61.21 to $61.36, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Based on recent 401(k) plan statement.
- All of the shares are currently exercisable.
Billionaire Hedge Funds
